Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$107.32 - $113.5 $219,576 - $232,221
-2,046 Reduced 1.54%
131,094 $14.3 Million
Q4 2022

Feb 14, 2023

BUY
$62.39 - $113.8 $1.5 Million - $2.74 Million
24,065 Added 22.06%
133,140 $15.2 Million
Q3 2022

Nov 14, 2022

SELL
$58.92 - $84.67 $74,415 - $106,938
-1,263 Reduced 1.14%
109,075 $6.75 Million
Q2 2022

Aug 15, 2022

SELL
$79.4 - $116.36 $62,646 - $91,808
-789 Reduced 0.71%
110,338 $8.8 Million
Q1 2022

May 16, 2022

BUY
$86.42 - $109.81 $9.6 Million - $12.2 Million
111,127 New
111,127 $11.7 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Capital Group Private Client Services, Inc. Portfolio

Follow Capital Group Private Client Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Private Client Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Private Client Services, Inc. with notifications on news.